Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 4, 2011, Pages 399-404

  Christensen, Søren Troels ^a   Søndergaard, Birthe ^a   Honoré, Per Hartvig ^a   Bjerrum, Ole Jannik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adverse drug reactions; Community pharmacy; Ibuprofen; Pharmacovigilance; Pharmacy students

Indexed keywords

IBUPROFEN;

ADULT; ARTICLE; CONSTIPATION; DIARRHEA; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; NAUSEA; PHARMACIST; PHARMACY; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; IBUPROFEN; INTERNSHIP, NONMEDICAL; MALE; MIDDLE AGED; STUDENTS, PHARMACY;

EID: 79953034120     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2069     Document Type: Article

References (19)

1. Nichols V, Thériault-Dubé I, Touzin J, et al. Risk perception and reasons for noncompliance in Pharmacovigilance-a qualitative study conducted in Canada. Drug Saf 2009; 32(2): 579-590. DOI: 10.2165/00002018-200932070-00004.
2. Foster JM, van der Molen T, de Jong-van den Berg LTW. Patient-reporting of side effects may provide an important source of information in clinical practice. Eur J Clin Pharmacol 2007; 63: 979-980. DOI: 10.1007/s00228-007-0339-8.
3. van Grootheest K, de Graaf L, de Jong-van den Berg LTW. Consumer Adverse Drug Reaction Reporting-A New Step in Pharmacovigilance? Drug Saf 2003; 26(4): 211-217. DOI: 10.2165/00002018-200326040-00001.
4. Blenkinsopp A, Wilkie P, Wang M. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2006; 62(2): 148-156. DOI: 10.1111/j.1365-2125.2006.02746.x.
5. (accessed November 16th 2009).
6. van Grootheest AC, Härmark L, Oosterhuis I, van Puijenbroek E. Lareb intensive monitoring, a web based system for monitoring ADRs in the postmarketing phase. Pharmacoepidemiol Drug Saf 2007; 16(S2): S252-S253. DOI: 10.1002/pds.
7. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions-a systematic review. Drug Saf 2006; 29(5): 385-396. DOI: 10.2165/00002018-200629050-00003.
8. Lopez-Gonzalez E, Herderio MT, Figueiras A. Determinants of under-reporting of adverse drug reactions-a systematic review. Drug Saf 2009; 32(1): 19-31. DOI: 10.2165/00002018-200932010-00002.
9. van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 205-210. DOI: 10.1002/pds.702.
10. Perrio MJ, Wilton LV, Shakir SAW. A Modified prescription-event monitoring study to assess the introduction of Seretide Evohaler™ in England-an example of studying risk monitoring in Pharmacovigilance. Drug Saf 2007; 30(8): 681-695. DOI: 10.2165/00002018-200730080-00005.
11. van Grootheest AC, Groote JK, de Jong-van den Berg LTW. Intensive monitoring of new drugs based on first signals from pharmacists: a pilot study. Pharmacoepidemiol Drug Saf 2003; 12: 475-481. DOI: 10.1002/pds.815.
12. Bührlen B, Reiß T, Beckmann C, Gassner UM, Gleiter CH. Assessment of the European community system of Pharmacovigilance. Stuttgart: Fraunhofer IRB 2006.
13. van Grootheest AC, Olsson S, Couper M, de Jong-van den Breg L. Pharmacists' role in reporting adverse drug reaction in an international perspective. Pharmacoepidemiol Drug Saf 2004; 13: 457-464. DOI: 10.1002/pds.897.
14. Granas AG, Buajordet M, Stenberg-Nielsen H, Harg P, Horn AM. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf 2007; 16: 429-434. DOI: 10.1002/pds.1298.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-245. DOI: 10.1038/clpt.1981.154.
16. Sørensen EW, Haugbølle LS. Using an action research process in pharmacy practice research-a cooperation project between university and internship pharmacies. Res Social Adm Pharm 2008; 4; 384-401. DOI: 10.1016/j.sapharm.2007.10.005.
17. Layton D, Sinclair HK, Bond CM, Hannaford PC, Shakir SAW. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Pharmacoepidemiol Drug Saf 2002; 11: 503-513. DOI: 10.1002/pds.734.
18. Emanueli A, Viaro D. Postmarketing Surveillance: Preliminary Results with a Nonsteroidal Antiinflammatory Drug. In Advances in Inflammation Research, Volume 6, KD, Rainsford, GP Velo (eds.). Raven Press: New York, 1984; 17-23.
19. Breckenridge A. The future of drug safety. Clin Pharmacol Ther 2007; 81(2): 161-163. DOI: 10.1038/sj.clpt.6100079.